Increased risk of pneumonia among patients with inflammatory bowel disease: A comparison between patients treated with biologic therapies and with conventional drugs | Zendy

AI Assistant Blog Pricing

Increased risk of pneumonia among patients with inflammatory bowel disease: A comparison between patients treated with biologic therapies and with conventional drugs

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.